Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and N/A. Always confirm against the full prescribing information.
100 interactions
Acebutolol
Atropine may increase the arrhythmogenic activities of Acebutolol.
Level 1 evidence
Adenosine
Atropine may increase the arrhythmogenic activities of Adenosine.
Level 1 evidence
Alfentanil
The risk or severity of adverse effects can be increased when Atropine is combined with Alfentanil.
Level 1 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Atropine is combined with Amifampridine.
Level 2 evidence
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Atropine.
Level 1 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Atropine is combined with Amisulpride.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Atropine.
Level 2 evidence
Amlodipine
Amlodipine may increase the arrhythmogenic activities of Atropine.
Level 1 evidence
Amobarbital
The risk or severity of adverse effects can be increased when Atropine is combined with Amobarbital.
Level 1 evidence
Amoxapine
The risk or severity of adverse effects can be increased when Atropine is combined with Amoxapine.
Level 2 evidence
Atazanavir
Atropine may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Level 2 evidence
Atenolol
Atenolol may increase the arrhythmogenic activities of Atropine.
Level 1 evidence
Enter your NPI to unlock 5 major interactions for N/A
N/A (Atropine Injection, 2 Mg) has 619 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
N/A (Atropine Injection, 2 Mg) has 52 major, 234 moderate, and 333 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and N/A. Always confirm against the full prescribing information.